Human Gene MIR744 (ENST00000578242.1) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Comparative Toxicogenomics Database (CTD)
|
|
The following chemicals interact with this gene
| |
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
DL492534 - Novel nucleic acids. HZ408756 - JP 2015528002-A/1353: CHIRAL CONTROL. HZ460733 - WO 2015190584-A/230: Kit or device and method for detecting prostate cancer. HZ461401 - WO 2015190586-A/214: Kit and method for detecting colon cancer. HZ462243 - WO 2015190591-A/398: Kit and method for detecting breast cancer. HZ463162 - WO 2015194535-A/256: Kit and method for detecting stomach cancer. HZ464541 - WO 2015194615-A/359: Kit or device and method for detecting hepatic cancer. HZ465289 - WO 2015194627-A/342: Kit and method for detecting esophageal cancer. LG052090 - KR 1020150036642-A/1356: CHIRAL CONTROL. LY496472 - KR 1020170018406-A/342: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY497044 - KR 1020170016485-A/214: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY498442 - KR 1020170018411-A/359: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY499246 - KR 1020170018412-A/398: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER. LY499975 - KR 1020170019425-A/256: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY500606 - KR 1020170016490-A/230: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LZ238824 - WO 2017171048-A/485: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas. MS869525 - Sequence 230 from Patent EP3156483. MS880561 - Sequence 398 from Patent EP3156498. MS884231 - Sequence 214 from Patent EP3156499. MS885094 - Sequence 256 from Patent EP3156503. MS994480 - Sequence 342 from Patent EP3159406. FW364589 - Oligonucleotides for modulating target RNA activity. HI964785 - Sequence 70 from Patent WO2010139812. HI966378 - Sequence 698 from Patent WO2010139811. HI967244 - Sequence 698 from Patent WO2010139810. HV595504 - JP 2010539959-A/885: Micromirs. HV953993 - JP 2012518421-A/905: METHODS OF DETECTING LUNG CANCER. HW122348 - JP 2013504331-A/7: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY. HW523246 - JP 2014507123-A/31: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS. HW798901 - WO 2014192907-A/7: Method for detecting miRNA used for differentiating disorders causing motor neuropathy. HZ074605 - JP 2013535982-A/696: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ082742 - JP 2015513906-A/99: Stem Cell Microparticles. HZ158061 - JP 2015130862-A/885: Micromirs. HZ186902 - JP 2015146814-A/651: Oligonucleotides for modulating target RNA activity. HZ436523 - JP 2015529450-A/99: Stem Cell Microparticles. HZ460547 - WO 2015190584-A/44: Kit or device and method for detecting prostate cancer. HZ461206 - WO 2015190586-A/19: Kit and method for detecting colon cancer. HZ461965 - WO 2015190591-A/120: Kit and method for detecting breast cancer. HZ462963 - WO 2015194535-A/57: Kit and method for detecting stomach cancer. HZ464323 - WO 2015194615-A/141: Kit or device and method for detecting hepatic cancer. HZ465075 - WO 2015194627-A/128: Kit and method for detecting esophageal cancer. HZ482579 - JP 2015535430-A/3085: TERMINALLY MODIFIED RNA. HZ792510 - JP 2016504050-A/4255: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA400823 - Sequence 70 from Patent WO2011080318. JA401801 - Sequence 70 from Patent WO2011080315. JA402808 - Sequence 70 from Patent WO2011080316. JA405439 - Sequence 70 from Patent EP2336353. JA427312 - Sequence 645 from Patent WO2011072177. JA428965 - Sequence 70 from Patent WO2011095623. JA660686 - Sequence 140 from Patent WO2011131354. JA682680 - Sequence 148 from Patent WO2011149354. JA715123 - Sequence 905 from Patent EP2401406. JA791797 - Sequence 199 from Patent WO2012089772. JA885401 - Sequence 31 from Patent WO2012083004. JB022643 - Sequence 485 from Patent WO2013026685. JB023104 - Sequence 358 from Patent WO2013026684. JB074943 - Sequence 203 from Patent WO2012168448. JB174990 - Sequence 22 from Patent WO2012101219. JB249283 - Sequence 51 from Patent EP2478360. JB620790 - Sequence 770 from Patent WO2013063544. JC171727 - Sequence 99 from Patent WO2013150303. JC244920 - Sequence 548 from Patent WO2012020308. JC244981 - Sequence 609 from Patent WO2012020308. JC249568 - Sequence 29 from Patent WO2011138457. JC515242 - Sequence 5495 from Patent WO2014113089. JC572538 - Sequence 99 from Patent WO2014125276. JC582226 - Sequence 99 from Patent WO2014125277. JE953922 - Sequence 99 from Patent WO2015052526. JE955675 - Sequence 99 from Patent WO2015052527. JE978695 - Sequence 140 from Patent EP2865765. LF137427 - JP 2016507550-A/99: Method of Producing Microparticles. LF160047 - JP 2016513950-A/113: Oligomers with improved off-target profile. LF162392 - JP 2016513095-A/99: Stem Cell Microparticles and miRNA. LF632757 - WO 2016117582-A/186: miRNA biomarkers for mental disorders. LF953144 - JP 2016534103-A/99: Stem Cell Microparticles and miRNA. LG005489 - KR 1020150004822-A/99: STEM CELL MICROPARTICLES. LG053185 - KR 1020150059168-A/99: STEM CELL MICROPARTICLES. LG240424 - KR 1020160035087-A/99: STEM CELL MICROPARTICLES AND MIRNA. LP727004 - Sequence 698 from Patent EP2883966. LP819274 - Sequence 698 from Patent EP3296406. LP928788 - Sequence 29 from Patent EP3181692. LP939216 - Sequence 698 from Patent EP3184651. LP951699 - Sequence 205 from Patent WO2017157650. LQ072830 - Sequence 3154 from Patent EP2964234. LQ278597 - Sequence 136 from Patent WO2016066288. LQ441196 - Sequence 203 from Patent EP3029157. LV470509 - JP 2016534036-A/99: Stem Cell Microparticles and miRNA. LX280720 - JP 2016105097-A/7: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY. LY405569 - KR 1020160117535-A/874: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY496258 - KR 1020170018406-A/128: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY496849 - KR 1020170016485-A/19: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY498224 - KR 1020170018411-A/141: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY498968 - KR 1020170018412-A/120: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER. LY499776 - KR 1020170019425-A/57: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY500420 - KR 1020170016490-A/44: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LZ234259 - JP 2017184756-A/651: Oligonucleotides for modulating target RNA activity. LZ234338 - JP 2017181518-A/7: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY. LZ238563 - WO 2017171048-A/224: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas. MA260808 - JP 2017505623-A/874: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA406057 - WO 2018155427-A/831: A probe with reduced false positive binding, a method to desing the probe, and the use thereof. MA420071 - JP 2018518169-A/122: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA646331 - JP 2017113010-A/4255: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA734215 - JP 2017140048-A/3085: TERMINALLY MODIFIED RNA. MP015347 - Sequence 550 from Patent WO2019016252. MS637911 - Sequence 28 from Patent WO2017037190. MS673555 - Sequence 358 from Patent EP3135774. MS833924 - Sequence 70 from Patent EP3112479. MS869339 - Sequence 44 from Patent EP3156483. MS880283 - Sequence 120 from Patent EP3156498. MS884036 - Sequence 19 from Patent EP3156499. MS884895 - Sequence 57 from Patent EP3156503. MS902012 - Sequence 485 from Patent EP3156505. MS994266 - Sequence 128 from Patent EP3159406. HZ460927 - WO 2015190584-A/424: Kit or device and method for detecting prostate cancer. HZ461587 - WO 2015190586-A/400: Kit and method for detecting colon cancer. HZ462530 - WO 2015190591-A/685: Kit and method for detecting breast cancer. HZ463355 - WO 2015194535-A/449: Kit and method for detecting stomach cancer. HZ464774 - WO 2015194615-A/592: Kit or device and method for detecting hepatic cancer. HZ465507 - WO 2015194627-A/560: Kit and method for detecting esophageal cancer. LY496690 - KR 1020170018406-A/560: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY497230 - KR 1020170016485-A/400: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY498675 - KR 1020170018411-A/592: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY499533 - KR 1020170018412-A/685: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER. LY500168 - KR 1020170019425-A/449: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LY500800 - KR 1020170016490-A/424: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD. LZ239122 - WO 2017171048-A/783: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas. MS869719 - Sequence 424 from Patent EP3156483. MS880848 - Sequence 685 from Patent EP3156498. MS884417 - Sequence 400 from Patent EP3156499. MS885287 - Sequence 449 from Patent EP3156503. MS994698 - Sequence 560 from Patent EP3159406. DL491003 - Novel nucleic acids. FW364590 - Oligonucleotides for modulating target RNA activity. FW371773 - Human-derived nuclear acids for inhibiting HIV protein expression. HI964784 - Sequence 69 from Patent WO2010139812. HI966279 - Sequence 599 from Patent WO2010139811. HI967145 - Sequence 599 from Patent WO2010139810. HV595505 - JP 2010539959-A/886: Micromirs. HW913485 - JP 2015504307-A/245: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS. HZ074606 - JP 2013535982-A/697: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ083129 - JP 2015513906-A/486: Stem Cell Microparticles. HZ158062 - JP 2015130862-A/886: Micromirs. HZ186903 - JP 2015146814-A/652: Oligonucleotides for modulating target RNA activity. HZ436910 - JP 2015529450-A/486: Stem Cell Microparticles. HZ482578 - JP 2015535430-A/3084: TERMINALLY MODIFIED RNA. HZ792509 - JP 2016504050-A/4254: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA400822 - Sequence 69 from Patent WO2011080318. JA401800 - Sequence 69 from Patent WO2011080315. JA402807 - Sequence 69 from Patent WO2011080316. JA405438 - Sequence 69 from Patent EP2336353. JA427181 - Sequence 514 from Patent WO2011072177. JA428964 - Sequence 69 from Patent WO2011095623. JA660698 - Sequence 152 from Patent WO2011131354. JA791618 - Sequence 20 from Patent WO2012089772. JA791980 - Sequence 29 from Patent WO2012089753. JB074894 - Sequence 154 from Patent WO2012168448. JB620791 - Sequence 771 from Patent WO2013063544. JB778866 - Sequence 245 from Patent WO2013078283. JC172114 - Sequence 486 from Patent WO2013150303. JC244982 - Sequence 610 from Patent WO2012020308. JC515241 - Sequence 5494 from Patent WO2014113089. JC572925 - Sequence 486 from Patent WO2014125276. JC582613 - Sequence 486 from Patent WO2014125277. JE954309 - Sequence 486 from Patent WO2015052526. JE956062 - Sequence 486 from Patent WO2015052527. JE978707 - Sequence 152 from Patent EP2865765. LF137814 - JP 2016507550-A/486: Method of Producing Microparticles. LF160988 - JP 2016513950-A/1054: Oligomers with improved off-target profile. LF162779 - JP 2016513095-A/486: Stem Cell Microparticles and miRNA. LF953531 - JP 2016534103-A/486: Stem Cell Microparticles and miRNA. LG005876 - KR 1020150004822-A/486: STEM CELL MICROPARTICLES. LG053572 - KR 1020150059168-A/486: STEM CELL MICROPARTICLES. LG240811 - KR 1020160035087-A/486: STEM CELL MICROPARTICLES AND MIRNA. LP726905 - Sequence 599 from Patent EP2883966. LP819175 - Sequence 599 from Patent EP3296406. LP939117 - Sequence 599 from Patent EP3184651. LQ072829 - Sequence 3153 from Patent EP2964234. LQ441147 - Sequence 154 from Patent EP3029157. LQ724406 - Sequence 39 from Patent WO2018096084. LV470896 - JP 2016534036-A/486: Stem Cell Microparticles and miRNA. LY405570 - KR 1020160117535-A/875: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ234260 - JP 2017184756-A/652: Oligonucleotides for modulating target RNA activity. MA260809 - JP 2017505623-A/875: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA646330 - JP 2017113010-A/4254: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA734214 - JP 2017140048-A/3084: TERMINALLY MODIFIED RNA. MS833923 - Sequence 69 from Patent EP3112479. MA806273 - WO 2018199275-A/533: Kit, device and method for detection of ovary tumor. MA803384 - JP 2018183181-A/4255: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA806002 - WO 2018199275-A/262: Kit, device and method for detection of ovary tumor. MA806559 - WO 2018199275-A/819: Kit, device and method for detection of ovary tumor. MA803383 - JP 2018183181-A/4254: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA822817 - WO 2019004436-A/630: Kit, device, and method for detection of lung cancer. MA822482 - WO 2019004436-A/295: Kit, device, and method for detection of lung cancer. MP129199 - Sequence 99 from Patent EP3470073. MP162122 - Sequence 99 from Patent WO2019069093. MA823147 - WO 2019004436-A/960: Kit, device, and method for detection of lung cancer. MP129586 - Sequence 486 from Patent EP3470073. MP162509 - Sequence 486 from Patent WO2019069093. MP280656 - Sequence 76 from Patent WO2019111197. MP283569 - Sequence 76 from Patent WO2019111198. LY616588 - KR 1020180129785-A/485: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR. LY616327 - KR 1020180129785-A/224: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR. LY616886 - KR 1020180129785-A/783: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR. MB119869 - WO 2019117270-A/71: Method of aiding detection of head and neck cancer. MB407124 - WO 2019159884-A/614: Kit, device, and method for detection of dementia. MB406728 - WO 2019159884-A/218: Kit, device, and method for detection of dementia. MB407552 - WO 2019159884-A/1042: Kit, device, and method for detection of dementia. MB473053 - WO 2019208671-A/452: Kit or device and method for detecting bladder cancer. MB472822 - WO 2019208671-A/221: Kit or device and method for detecting bladder cancer. MB473219 - WO 2019208671-A/618: Kit or device and method for detecting bladder cancer. MC002628 - WO 2020027098-A/25: A method for quality evaluation of body fluid sample. MC002612 - WO 2020027098-A/9: A method for quality evaluation of body fluid sample. MP395075 - Sequence 173 from Patent EP3565903.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: NR_030613, uc021tqg.1 UCSC ID: ENST00000578242.1 RefSeq Accession: NR_030613
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|